| |
| SEPTEMBER 2008 |
|
Aquestion of Quality
Reducing costs is an everyday
challenge. Sourcing APIs in
emerging markets is one
answer, but are today’s
standards enough to protect
public health? Dr Susanne
Keitel, EDQM, finds out.
view pdf |
Cold Chain Challenge
Vaclav Sulista, Novartis, and Jyrki Syväri, Boehringer Ingelheim, call
for a common understanding of the specific requirements of the
cold chain in order to realise potential business benefits.
view pdf |
We Can Work it Out
The outsourcing of clinical trials continues to grow in popularity and managing relationships with CROs in an effective and efficient way is crucial to
the success of a clinical trial project.
Janet Edwards, AstraZeneca, and Susan Sforzini, LEO Pharma, discuss the issues to be considered. view pdf
|
Clinical Stress Test
Increasing demands on the pharmaceutical industry to develop drug candidates for clinical therapy quickly have challenged scientists to expedite the drug discovery and development process. Robyn A Rourick, James Gallagher and John P Walsh, Kalypsys Inc Pharmaceutical Sciences, discuss the integration of a modular chemical and photo-stability chamber for profiling degradants in drug substances. view pdf |
Perfect Delivery
An accurate dose of insulin has to be taken daily by millions of people and yet fear of injections leads many to delay starting their medicine, with great detriment to their life expectancy. Professor Stephen Bloom and Doctor Sagen Zac-Varghese, Imperial College London, discuss the various delivery methods used to fulfil the demand for a safe, efficient and cost-effective needle-free method. view pdf |
Breathing Lessons
Commercial and regulatory realities can be obstacles to progress towards paediatric-specific inhalers currently used for adults. Ken Bruce, Ben Forbes and nilesh Patel, King’s College london, explore the rationale for passively targeting the lung via inhalation for the treatment of respiratory infection, and discuss the need for more research.
view pdf
|
From Farmer to Pharma
Nigel Brooksby’s pharmaceutical career
has spanned an impressive 30 years. As
sanofi-aventis UK managing director, he is clear in his vision of the challenges facing the industry in a competitive and volatile market. But what are those challenges, how can they be addressed and, more importantly, who is the man behind the title? Andrew Tunnicliffe finds out. view pdf |
Electronic Interaction
electronic collaboration has become critical to a company’s success. Ron charity, Joel Jankow and Heinz Thommen, HP, discuss the need to integrate an electronic collaboration strategy within today’s pharma business and highlight tools that can be used to realise real business benefits.
view pdf |
|
Making a Move on Pharma
A pharmaceutical company can have a
number of positive effects for the area in which it is located and the incentives to move to certain areas can be very attractive. Barry Mansfield investigates the mitigating factors that need to be considered before the decision to
locate is made.
view pdf
|
On The Right Track
Safety and security of pharmaceuticals are at the forefront of industry concerns. As a result, numerous costly and incompatible solutions have been proposed to industry and government stakeholders. Ulrike Kreysa and Jan Denecker, GS1, explain why the GS1
System of Standards is well suited for drug traceability. view pdf |
Safety System
As recent studies conclude that some
already-to-market drugs may be linked to serious illness, it has never been more important for pharma to be fully protected. John K Jenkins and Joseph C Famulare, US FDA, discuss the steps manufacturers should take to ensure adequate cover.
view pdf |
